Northern Trust’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.9M | Buy |
341,842
+42,623
| +14% | +$985K | ﹤0.01% | 2205 |
|
|
2025
Q1 | $8.08M | Sell |
299,219
-9,581
| -3% | -$259K | ﹤0.01% | 2167 |
|
|
2024
Q4 | $16.5M | Buy |
308,800
+42,302
| +16% | +$2.26M | ﹤0.01% | 1817 |
|
|
2024
Q3 | $12.1M | Buy |
266,498
+72,125
| +37% | +$3.28M | ﹤0.01% | 1958 |
|
|
2024
Q2 | $8.14M | Sell |
194,373
-7,610
| -4% | -$319K | ﹤0.01% | 2106 |
|
|
2024
Q1 | $7.6M | Sell |
201,983
-2,019
| -1% | -$76K | ﹤0.01% | 2220 |
|
|
2023
Q4 | $2.19M | Buy |
204,002
+11,317
| +6% | +$121K | ﹤0.01% | 2950 |
|
|
2023
Q3 | $1.94M | Buy |
192,685
+5,395
| +3% | +$54.4K | ﹤0.01% | 2960 |
|
|
2023
Q2 | $2.22M | Buy |
187,290
+47,319
| +34% | +$562K | ﹤0.01% | 2952 |
|
|
2023
Q1 | $1.69M | Buy |
139,971
+243
| +0.2% | +$2.94K | ﹤0.01% | 3006 |
|
|
2022
Q4 | $1.84M | Buy |
139,728
+3,364
| +2% | +$44.3K | ﹤0.01% | 3047 |
|
|
2022
Q3 | $1.85M | Buy |
136,364
+3,207
| +2% | +$43.4K | ﹤0.01% | 3048 |
|
|
2022
Q2 | $1.63M | Sell |
133,157
-7,090
| -5% | -$86.5K | ﹤0.01% | 3168 |
|
|
2022
Q1 | $2.01M | Buy |
140,247
+24,752
| +21% | +$355K | ﹤0.01% | 3103 |
|
|
2021
Q4 | $2.28M | Sell |
115,495
-1,466
| -1% | -$28.9K | ﹤0.01% | 3161 |
|
|
2021
Q3 | $2.53M | Buy |
+116,961
| New | +$2.53M | ﹤0.01% | 3150 |
|